Holders — by stockHoldings — by fund
Birchview Capital, LP
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-06-30 · filed with the SEC up to 45 days after quarter end · CIK 0001618205
$213.8M
disclosed book value
72
positions
25.2%
largest position share
Positions, as of 2026-06-30
top 73 of 72 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | KLACKLA CORPORATION | 178,471 | $53.8M | 25.2% |
| 2 | BMYBRISTOL-MYERS SQUIBB CO | 297,243 | $17.1M | 8% |
| 3 | LRCXLAM RESEARCH CORPORATION | 35,000 | $15.2M | 7.1% |
| 4 | SLDBSOLID BIOSCIENCES INC | 666,196 | $6.7M | 3.1% |
| 5 | NTLAINTELLIA THERAPEUTICS INC | 385,400 | $6.5M | 3% |
| 6 | BIODESIX INC | 286,804 | $6.5M | 3% |
| 7 | STOKSTOKE THERAPEUTICS INC | 178,110 | $5.8M | 2.7% |
| 8 | OVVOVINTIV INC | 107,500 | $5.7M | 2.6% |
| 9 | NKTRNEKTAR THERAPEUTICS | 81,000 | $5.7M | 2.6% |
| 10 | CORTCORCEPT THERAPEUTICS INC | 57,200 | $5.0M | 2.3% |
| 11 | NBIXNEUROCRINE BIOSCIENCES INC | 27,190 | $4.6M | 2.1% |
| 12 | PRTAPROTHENA CORP PLC | 449,019 | $4.4M | 2.1% |
| 13 | ACADACADIA PHARMACEUTICALS INC | 171,000 | $4.3M | 2% |
| 14 | PTGXPROTAGONIST THERAPEUTICS INC | 35,018 | $4.3M | 2% |
| 15 | CMPXCOMPASS THERAPEUTICS INC | 1.7M | $3.7M | 1.7% |
| 16 | RLMDRELMADA THERAPEUTICS INC | 408,100 | $2.8M | 1.3% |
| 17 | ALKSALKERMES PLC | 50,000 | $2.6M | 1.2% |
| 18 | HALOHALOZYME THERAPEUTICS INC | 33,251 | $2.6M | 1.2% |
| 19 | CLDXCELLDEX THERAPEUTICS INC | 69,900 | $2.6M | 1.2% |
| 20 | CYTKCYTOKINETICS INC | 30,000 | $2.6M | 1.2% |
| 21 | OLMAOLEMA PHARMACEUTICALS INC | 199,000 | $2.5M | 1.2% |
| 22 | VERAVERA THERAPEUTICS INC | 57,758 | $2.5M | 1.2% |
| 23 | UTHRUNITED THERAPEUTICS CORP | 4,506 | $2.4M | 1.1% |
| 24 | ZBIOZENAS BIOPHARMA INC | 93,601 | $2.4M | 1.1% |
| 25 | QUREUNIQURE NV | 50,697 | $2.3M | 1.1% |
| 26 | PACBPACIFIC BIOSCIENCES OF CALIFORNIA INC | 1.4M | $2.3M | 1.1% |
| 27 | ABVXABIVAX SA | 17,000 | $2.3M | 1.1% |
| 28 | VIRVIR BIOTECHNOLOGY INC | 220,000 | $2.2M | 1% |
| 29 | BIIBBIOGEN INC | 9,000 | $1.9M | 0.9% |
| 30 | EQTEQT CORPORATION | 34,619 | $1.8M | 0.9% |
| 31 | BIOABIOAGE LABS INC | 69,000 | $1.7M | 0.8% |
| 32 | TVTXTRAVERE THERAPEUTICS INC | 29,000 | $1.6M | 0.8% |
| 33 | QDELUSDQUIDELORTHO CORP | 89,377 | $1.6M | 0.7% |
| 34 | AXSMAXSOME THERAPEUTICS INC | 6,000 | $1.5M | 0.7% |
| 35 | FHTXFOGHORN THERAPEUTICS INC | 281,937 | $1.4M | 0.6% |
| 36 | BCYCBICYCLE THERAPEUTICS PLC | 313,616 | $1.3M | 0.6% |
| 37 | GPCRSTRUCTURE THERAPEUTICS INC | 24,000 | $1.3M | 0.6% |
| 38 | XENEXENON PHARMACEUTICALS INC | 21,032 | $1.3M | 0.6% |
| 39 | NVONOVO NORDISK A/S | 24,000 | $1.2M | 0.5% |
| 40 | FCXFREEPORT-MCMORAN CL-B | 18,035 | $1.1M | 0.5% |
| 41 | IMNMIMMUNOME INC | 50,000 | $1.1M | 0.5% |
| 42 | PHVSPHARVARIS N V | 29,847 | $1.0M | 0.5% |
| 43 | HROWHARROW HEALTH INC | 24,000 | $1.0M | 0.5% |
| 44 | ADAGADAGENE INC | 240,000 | $1.0M | 0.5% |
| 45 | DFTXDEFINIUM THERAPEUTICS INC | 20,000 | $940,800 | 0.4% |
| 46 | SLNSILENCE THERAPEUTICS PLC | 71,218 | $781,974 | 0.4% |
| 47 | BBIOBRIDGEBIO PHARMA INC | 8,741 | $651,030 | 0.3% |
| 48 | FDMT4D MOLECULAR THERAPEUTICS INC | 48,505 | $645,117 | 0.3% |
| 49 | URGNUROGEN PHARMA LTD | 16,487 | $606,722 | 0.3% |
| 50 | PHATPHATHOM PHARMACEUTICALS INC | 55,000 | $596,750 | 0.3% |
| 51 | CAMPCAMP4 THERAPEUTICS CORP | 120,000 | $524,400 | 0.2% |
| 52 | SVRASAVARA INC | 80,000 | $492,800 | 0.2% |
| 53 | CADLCANDEL THERAPEUTICS INC | 47,756 | $491,887 | 0.2% |
| 54 | ALTALTIMMUNE INC | 152,681 | $464,150 | 0.2% |
| 55 | CMPSCOMPASS PATHWAYS LTD | 30,000 | $424,500 | 0.2% |
| 56 | KPTIEURKARYOPHARM THERAPEUTICS INC | 42,952 | $419,641 | 0.2% |
| 57 | CGEMCULLINAN THERAPEUTICS INC | 20,000 | $364,200 | 0.2% |
| 58 | TRINTRINITY CAP INC | 20,000 | $357,800 | 0.2% |
| 59 | CAPRCAPRICOR THERAPEUTICS INC | 14,352 | $345,596 | 0.2% |
| 60 | CSTLCASTLE BIOSCIENCES INC | 12,984 | $309,668 | 0.1% |
| 61 | IVVDINVIVYD INC | 342,275 | $298,601 | 0.1% |
| 62 | GRCEGRACE THERAPEUTICS INC | 120,000 | $272,400 | 0.1% |
| 63 | KBDCKAYNE ANDERSON BDC INC | 20,000 | $270,600 | 0.1% |
| 64 | VYGRVOYAGER THERAPEUTICS INC | 75,147 | $263,015 | 0.1% |
| 65 | LUNGPULMONX CORP | 200,543 | $260,706 | 0.1% |
| 66 | NTLAINTELLIA THERAPEUTICS INC (NTLA) C @ 13.0 10/16/2026 | 500 | $260,000 | 0.1% |
| 67 | OCULOCULAR THERAPEUTIX INC | 20,655 | $202,832 | 0.1% |
| 68 | KYNBKYNTRA BIO INC | 22,566 | $170,373 | 0.1% |
| 69 | ELUTELUTIA INC | 165,094 | $161,726 | 0.1% |
| 70 | QNRXQUOIN PHARMACEUTICALS LTD | 20,000 | $96,800 | 0% |
| 71 | LPCNLIPOCINE INC | 16,712 | $42,783 | 0% |
| 72 | DCGODOCGO INC | 39,062 | $20,160 | 0% |
| 73 | GOSSGOSSAMER BIO INC | 18,176 | $2,992 | 0% |
Source: SEC Form 13F-HR, reporting period 2026-06-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.